Form 4 for FENC FENNEC PHARMACEUTICALS INC.
Accepted 2024-12-02 00:00:00 ET · period of report 2024-12-02 · accession 0001415889-24-028018 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-02 | 2024-12-02 | FENC | RALLIS CHRIS A | Dir | S - Sale+OE | $6.14 | -6,409 | 52.2K | -11% | -$39.4K |
| D | 2024-12-02 | 2024-12-02 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.69 | +10.0K | 58.6K | +21% | +$26.9K |
| D | 2024-12-02 | 2024-12-02 | FENC | RALLIS CHRIS A | Dir | M - OptEx | $2.69 | -10.0K | 184.7K | -5% | -$26.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-12-02 | S | D | 6,409 | $6.14 | 52,214 | D | — | — | (F2) Shares sold to satisfy tax obligation on option exercise. |
| 2 | Common | Common Shares | 2024-12-02 | M | A | 10,000 | $2.69 | 58,623 | D | — | — | (F1) Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023. |
| 3 | Derivative | Common Shares | 2024-12-02 | M | D | 10,000 | $2.69 | 184,698 | D | $2.69 · 2014-12-31 to 2024-12-31 | 10,000 Options | (F3) Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023. |